EUCTR2008-001468-34-IT进行中（未招募）不适用
Phase III clinical trial multicenter randomized for the evaluation of the safety and efficacy of the combined treatment of intravitreal triamcinolone and photodynamic therapy versus intravitreal Bevacizumab and photodynamic therapy versus intravitreal Bevacizumab for the treatment of neo-vascular maculopathy type retinal angiomatous prolipheration (RAP). - ND
AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)0 个研究点开始时间: 2009年3月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Signed informed consent.
- •Age > 50 year.
- •RAP stage II and III.
- •BCVA with ETDRS between 20/40 and 20/320.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Decompensated blood hypertension.
- •Thromboembolic events within 6 months, including TIA, cerebral stroke, and myocardial infarction.
- •Impossibility to document the lesion via FA, ICG, angiography, color photos of fundus oculi,OCT.
- •Any other condition that could compromize visual acuity.
研究者
相似试验
进行中（未招募）
1 期
Oral treatment to evaluate the analgesic efficacy and safety of paracetamol / ibuprofen 500/200 mg compared with 500 mg paracetamol alone, ibuprofen 200 mg alone and placebo in patients with primary dysmenorrheaMODERATE TO SEVERE PAIN FOLLOWING DYSMENORRHOEAEUCTR2015-002446-31-ESABORATORIOS FARMALIDER S.A.
招募中
1 期
Multicenter randomized Phase III trial evaluating contact X-ray brachytherapy for rectal preservation in intermediate substage rectal adenocarcinoma (TRESOR)Adult patients with intermediate low or mid rectal adenocarcinoma to be treated with total neoadjuvant therapy (TNT) potentially eligible for rectal preservation.MedDRA version: 21.0Level: PTClassification code: 10038019Term: Rectal adenocarcinoma Class: 100000004864CTIS2023-506885-30-00Institut Gustave Roussy212
招募中
3 期
Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapyC92Myeloid leukaemiaDRKS00023646niversitätsklinikum Freiburg256
进行中（未招募）
1 期
Evaluation of the safety of 2 schedules of cabazitaxel (bi-weekly versus tri-weekly) plus prednisone in elderly men (= 70 years) with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing regimen (CABASTY)Metastatic castration-resistant prostate cancer (mCRPC)EUCTR2016-001179-60-NLA.R.T.I.C (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie)170
已完成
3 期
Randomized multicenter, phase III trial evaluating the safety of 2 schedules of cabazitaxel (bi-weekly versus tri-weekly) plus prednisone in elderly men (= 65years) with metastatic castration resistant prostate cancer (mCRPC) previously treated with a docetaxel-containing regimeC61Malignant neoplasm of prostateDRKS00017467Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (ARTIC)Georges Pompidou European Hospital180